Table 2

Baseline characteristics of the recruited subjects

Total (N=112)HD (n=60)PD (n=52)
Age (years)55.3±12.158.9±9.651.1±13.3
Male gender, n (%)74 (66.1)44 (73.3)30 (57.7)
Primary disease, n (%)
 Chronic nephritis49 (43.8)18 (30.0)31 (59.6)
 Diabetic kidney disease25 (22.3)16 (26.7)9 (17.3)
 Hypertensive nephrosclerosis6 (5.4)3 (5.0)3 (5.8)
 Uric acid nephropathy2 (1.8)2 (3.3)0 (0)
 Polycystic kidney disease2 (1.8)1 (1.7)1 (1.9)
 Lupus nephritis2 (1.8)1 (1.7)1 (1.9)
 Others3 (2.7)2 (3.3)1 (1.9)
 Unknown23 (20.5)17 (28.3)6 (11.5)
Dialysis vintage (months)57.1 (28.7–90.3)74.7 (31.1–141.5)52.4 (18.0–71.6)
spKt/V1.39 (1.29–1.56)
URR (%)69.1±6.0
Total weekly Kt/V1.85±0.30
OH (L)1.8 (0.8–3.1)1.5 (0.6–2.5)2.2 (0.9–3.8)
NT-proBNP (pg/mL)8250 (3805–13 222)7500 (3702–14 134)8406 (4232–12 965)
LVMI (g/m2)116.3 (100.4–136.7)117.0 (101.1–133.1)112.1 (96.4–142.1)
LVEF (%)63.5±5.563.1±5.663.9±5.4
  • Data are presented as frequencies and percentages for categorical variables, mean±SD for normally distributed continuous variables and median (IQR) for non-normally distributed continuous variables.

  • HD, haemodialysis; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; OH, overhydration; PD, peritoneal dialysis; SpKt/V, single-pool Kt/V; URR, urea reduction ratio.